Literature DB >> 16483743

Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.

Doan Thi Thanh Huong1, Yoko Takahashi, Takashi Ide.   

Abstract

OBJECTIVE: We investigated the physiologic activity of citrus flavonoids, naringenin, and hesperetin in affecting the activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation and serum and liver lipid levels in male ICR mice.
METHODS: Six-week-old male ICR mice were fed experimental diets containing 1% naringenin or hesperetin and a control diet free of citrus flavonoids for 21 d.
RESULTS: Naringenin caused a significant 56.1% increase in the hepatic cyanide-insensitive palmitoyl-coenzyme A oxidation rate. This compound also caused significant increases ranging from 9.8% to 55.6% in activity levels of various enzymes involved in hepatic fatty acid oxidation. These increases were accompanied by upregulation of gene expression of enzymes involved in peroxisomal fatty acid oxidation including increases of 46.8% to 88.7% of carnitine octanoyltransferase, acyl-coenzyme A oxidase, bifunctional enzyme, and 3-ketoacyl-coenzyme A thiolase. Messenger RNA levels of mitochondrial proteins involved in fatty acid oxidation except for trifunctional enzyme subunit-beta were not affected by naringenin. Naringenin also significantly increased more than five-fold the mRNA level of microsomal cytochrome P-450 IV A1 involved in omega-oxidation of fatty acids. However, hesperetin did not affect any parameter of hepatic fatty acid oxidation. Naringenin, but not hesperetin, significantly lowered serum levels of triacylglycerol, cholesterol, phospholipids, and free fatty acid.
CONCLUSION: We demonstrated that naringenin has the physiologic effect of increasing hepatic fatty acid oxidation through upregulation of gene expression of enzymes involved in peroxisomal beta-oxidation in mice. The change may account for the propensity of this compound to lower serum lipid levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483743     DOI: 10.1016/j.nut.2005.11.006

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  19 in total

1.  Naringenin modulates skeletal muscle differentiation via estrogen receptor α and β signal pathway regulation.

Authors:  Marco Pellegrini; Pamela Bulzomi; Paola Galluzzo; Marco Lecis; Stefano Leone; Valentina Pallottini; Maria Marino
Journal:  Genes Nutr       Date:  2014-08-26       Impact factor: 5.523

2.  Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.

Authors:  Jonathan Goldwasser; Pazit Y Cohen; Wenyu Lin; Danny Kitsberg; Patrick Balaguer; Stephen J Polyak; Raymond T Chung; Martin L Yarmush; Yaakov Nahmias
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

3.  Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats.

Authors:  Kae Won Cho; Yong Ook Kim; Juan E Andrade; John R Burgess; Young-Cheul Kim
Journal:  Eur J Nutr       Date:  2010-06-23       Impact factor: 5.614

4.  Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.

Authors:  Erin E Mulvihill; Emma M Allister; Brian G Sutherland; Dawn E Telford; Cynthia G Sawyez; Jane Y Edwards; Janet M Markle; Robert A Hegele; Murray W Huff
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

5.  Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.

Authors:  Jonathan Goldwasser; Pazit Y Cohen; Eric Yang; Patrick Balaguer; Martin L Yarmush; Yaakov Nahmias
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

6.  Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse.

Authors:  Edwina-S Baskin-Bey; Akira Anan; Hajime Isomoto; Steven-F Bronk; Gregory-J Gores
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

7.  Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.

Authors:  Yaakov Nahmias; Jonathan Goldwasser; Monica Casali; Daan van Poll; Takaji Wakita; Raymond T Chung; Martin L Yarmush
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

8.  Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome.

Authors:  Sriramajayam Kannappan; Carani Venkatraman Anuradha
Journal:  Eur J Nutr       Date:  2009-09-02       Impact factor: 5.614

9.  Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected].

Authors:  Maria Shulman; Merav Cohen; Alejandro Soto-Gutierrez; Hiroshi Yagi; Hongyun Wang; Jonathan Goldwasser; Carolyn W Lee-Parsons; Ofra Benny-Ratsaby; Martin L Yarmush; Yaakov Nahmias
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

10.  Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation.

Authors:  Erin E Mulvihill; Murray W Huff
Journal:  PPAR Res       Date:  2012-05-30       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.